User login
Introducing a New, Private Community Just for AGA’s Trainee and Early Career Members
Networking is an important part of your career, between connecting with mentors, gaining valuable referrals and tackling that next rung on the career ladder. AGA created the Early Career Group in the AGA Community to help you connect and network through the forum and directory, but also to provide education tools you’re not going to find anywhere else.
In case you haven’t yet taken a tour, the group creates an open dialogue for trainees and early career members up to seven years out of training. Each month will host a new theme and corresponding presentation, webinars, journal articles or tip sheets, as well as other member-only online events, such as forums with leading experts in the field.
Also, the group’s event calendar will help you stay on top of important deadlines, conferences and possibly even local meet-ups.
Visit http://Community.Gastro.org/EarlyCareerGroup/ today to take advantage of this collaboration space created just for you.
18 GIs to Watch: The Newest Class of AGA Future Leaders
AGA has announced the second class of its Future Leaders Program, which was created in 2015 to identify early career gastroenterologists who have the potential to make a significant impact on the specialty. The 18 gastroenterologists selected to participate in the 2017-2018 program stood out for their current achievements, commitment to advancing the field, and potential for future success.
“AGA relies heavily on the engagement and expertise of volunteer leaders to develop programs that continue to advance our specialty and support our members through changes to the health-care delivery landscape,” said Suzanne Rose, MD, MSEd, AGAF, co-program chair for the AGA Future Leaders Program. “The newest class of AGA Future Leaders shows exceptional promise and dedication to the field, and we look forward to working with these rising stars to cultivate the future leaders of AGA and the field of gastroenterology.”
The AGA Future Leaders Program provides a pathway within AGA for selected participants who seek opportunities to support the gastroenterology profession, advance their careers, connect with potential mentors and develop the leadership skills necessary to serve the organization. During this year-long program, participants will receive leadership training and work closely with AGA mentors on projects linked to AGA’s Strategic Plan.
AGA is pleased to announce the second class of the Future Leaders program:
- Arthur Beyder, MD, PhD, Assistant Professor, Mayo Clinic-Rochester
- Brigid S. Boland, MD, Assistant Adjunct Professor of Medicine, University of California, San Diego
- Lea Ann Chen, MD, Assistant Professor of Medicine, New York University School of Medicine, NY
- Bruno P. Chumpitazi, MD, MPH, Director, Neurogastroenterology and Motility Program, Texas Children’s Hospital/Baylor College of Medicine, Houston, TX
- Matthew A. Ciorba, MD, Assistant Professor of Medicine, Washington University in St. Louis, MO
- Katherine S. Garman, MD, Assistant Professor of Medicine, Duke University Medical Center, Durham, NC
- Christina Y. Ha, MD, Assistant Professor of Medicine, University of Los Angeles, David Geffen School of Medicine, CA
- Bryson W. Katona, MD, MS, PhD, Instructor, University of Pennsylvania, Philadelphia
- Peter S. Liang, MD, MPH, Instructor, NYU/Manhattan VA, New York, NY
- Folasade P. May, MD, PhD, MPhil, Assistant Professor of Medicine, David Geffen School of Medicine at the University of California, Los Angeles; Department of Veterans Affairs, Los Angeles, CA
- Marty M. Meyer, MD, Gastroenterologist, The Ohio State University, Columbus, OH
- Susan N. Ramdhaney, MD, AGAF, Gastroenterologist, President Comprehensive Digestive Care, Manhasset, NY
- Jonathan A. Rosenberg, MD, Gastroenterologist, Illinois Gastroenterology Group, Highland Park
- N. Jewel Samadder, MD, Assistant Professor of Medicine, Huntsman Cancer Institute, Salt Lake City, UT
- Siddharth Singh, MD, Assistant Professor of Medicine, University of California, San Diego
- Maria I. Vazquez-Roque, MD, MSc, Gastroenterologist, Mayo Clinic, Jacksonville, FL
- Sachin B. Wani, MD, Associate Professor of Medicine, University of Colorado, Aurora
- Jennifer Weiss, MD, MS, Assistant Professor, University of Wisconsin School of Medicine and Public Health, Madison
Learn more about the AGA Future Leaders program on the AGA website: www.gastro.org.
New AGA Guidelines
AGA recently released new clinical guidelines that provide evidence-based recommendations to help guide your clinical practice decisions based on rigorous systematic reviews of the medical literature.
AGA Institute Guideline on the Management of Crohn’s Disease After Surgical Resection: AGA developed this guideline, technical review and Clinical Decision Support Tool to outline strategies to reduce disease recurrence in Crohn’s disease patients who have achieved remission following bowel resection. Prevention of endoscopic recurrence, a strong surrogate measure of surgical recurrence, was evaluated for the development of the guideline.
The guidelines are intended to reduce practice variation and promote high-value care. The current evidence supports the early prophylactic use of thiopurines and/or anti-TNF therapy in patients who are at higher risk for clinical recurrence. However, some patients at lower risk may opt for close endoscopic monitoring instead. Although all patients should undergo ileocolonoscopy at six to 12 months after surgical resection, surveillance for endoscopic recurrence is most important for patients not on any pharmacological prophylaxis. In general, those with endoscopic recurrence should undergo treatment with anti-TNF and/or thiopurine therapy.
This guideline is available in the January issue of Gastroenterology.
AGA Institute Guidelines for the Diagnosis and Management of Acute Liver Failure: AGA developed this guideline and technical review to provide recommendations about controversial diagnostic and treatment strategies and predictive models for outcome of acute liver failure (ALF), which have arisen since acute liver failure is difficult to study in randomized clinical trials.
Recommendations include a strong recommendation for the use of N-acetyl cysteine (NAC) in patients with ALF related to acetaminophen, but there remains a lack of data to allow recommendations for testing for Wilson’s disease and varicella zoster virus in patients with ALF. Although there are low-quality data, because there are therapies that may be beneficial in patients with ALF, recommendations to test for herpes simplex virus and autoimmune hepatitis are supported, as is hepatitis E virus testing in pregnant women with ALF.
This guideline is available in the February issue of Gastroenterology.
Announcing New Crohn’s & Colitis Congress
AGA and the Crohn’s & Colitis Foundation are partnering to co-sponsor a new annual conference for health-care professionals and researchers. By joining the nation’s leading IBD patient organization with the premier GI professional organization, this will be the must-attend IBD conference, bringing state-of-the-art comprehensive care together with the latest research to advance prevention, treatment and cures for IBD patients.
Save the date – Jan. 18-20, 2018, in Las Vegas. Get ready to expand your knowledge, network with other leaders, and be inspired! Stay tuned for our website launch and more details coming this spring.
Introducing a New, Private Community Just for AGA’s Trainee and Early Career Members
Networking is an important part of your career, between connecting with mentors, gaining valuable referrals and tackling that next rung on the career ladder. AGA created the Early Career Group in the AGA Community to help you connect and network through the forum and directory, but also to provide education tools you’re not going to find anywhere else.
In case you haven’t yet taken a tour, the group creates an open dialogue for trainees and early career members up to seven years out of training. Each month will host a new theme and corresponding presentation, webinars, journal articles or tip sheets, as well as other member-only online events, such as forums with leading experts in the field.
Also, the group’s event calendar will help you stay on top of important deadlines, conferences and possibly even local meet-ups.
Visit http://Community.Gastro.org/EarlyCareerGroup/ today to take advantage of this collaboration space created just for you.
18 GIs to Watch: The Newest Class of AGA Future Leaders
AGA has announced the second class of its Future Leaders Program, which was created in 2015 to identify early career gastroenterologists who have the potential to make a significant impact on the specialty. The 18 gastroenterologists selected to participate in the 2017-2018 program stood out for their current achievements, commitment to advancing the field, and potential for future success.
“AGA relies heavily on the engagement and expertise of volunteer leaders to develop programs that continue to advance our specialty and support our members through changes to the health-care delivery landscape,” said Suzanne Rose, MD, MSEd, AGAF, co-program chair for the AGA Future Leaders Program. “The newest class of AGA Future Leaders shows exceptional promise and dedication to the field, and we look forward to working with these rising stars to cultivate the future leaders of AGA and the field of gastroenterology.”
The AGA Future Leaders Program provides a pathway within AGA for selected participants who seek opportunities to support the gastroenterology profession, advance their careers, connect with potential mentors and develop the leadership skills necessary to serve the organization. During this year-long program, participants will receive leadership training and work closely with AGA mentors on projects linked to AGA’s Strategic Plan.
AGA is pleased to announce the second class of the Future Leaders program:
- Arthur Beyder, MD, PhD, Assistant Professor, Mayo Clinic-Rochester
- Brigid S. Boland, MD, Assistant Adjunct Professor of Medicine, University of California, San Diego
- Lea Ann Chen, MD, Assistant Professor of Medicine, New York University School of Medicine, NY
- Bruno P. Chumpitazi, MD, MPH, Director, Neurogastroenterology and Motility Program, Texas Children’s Hospital/Baylor College of Medicine, Houston, TX
- Matthew A. Ciorba, MD, Assistant Professor of Medicine, Washington University in St. Louis, MO
- Katherine S. Garman, MD, Assistant Professor of Medicine, Duke University Medical Center, Durham, NC
- Christina Y. Ha, MD, Assistant Professor of Medicine, University of Los Angeles, David Geffen School of Medicine, CA
- Bryson W. Katona, MD, MS, PhD, Instructor, University of Pennsylvania, Philadelphia
- Peter S. Liang, MD, MPH, Instructor, NYU/Manhattan VA, New York, NY
- Folasade P. May, MD, PhD, MPhil, Assistant Professor of Medicine, David Geffen School of Medicine at the University of California, Los Angeles; Department of Veterans Affairs, Los Angeles, CA
- Marty M. Meyer, MD, Gastroenterologist, The Ohio State University, Columbus, OH
- Susan N. Ramdhaney, MD, AGAF, Gastroenterologist, President Comprehensive Digestive Care, Manhasset, NY
- Jonathan A. Rosenberg, MD, Gastroenterologist, Illinois Gastroenterology Group, Highland Park
- N. Jewel Samadder, MD, Assistant Professor of Medicine, Huntsman Cancer Institute, Salt Lake City, UT
- Siddharth Singh, MD, Assistant Professor of Medicine, University of California, San Diego
- Maria I. Vazquez-Roque, MD, MSc, Gastroenterologist, Mayo Clinic, Jacksonville, FL
- Sachin B. Wani, MD, Associate Professor of Medicine, University of Colorado, Aurora
- Jennifer Weiss, MD, MS, Assistant Professor, University of Wisconsin School of Medicine and Public Health, Madison
Learn more about the AGA Future Leaders program on the AGA website: www.gastro.org.
New AGA Guidelines
AGA recently released new clinical guidelines that provide evidence-based recommendations to help guide your clinical practice decisions based on rigorous systematic reviews of the medical literature.
AGA Institute Guideline on the Management of Crohn’s Disease After Surgical Resection: AGA developed this guideline, technical review and Clinical Decision Support Tool to outline strategies to reduce disease recurrence in Crohn’s disease patients who have achieved remission following bowel resection. Prevention of endoscopic recurrence, a strong surrogate measure of surgical recurrence, was evaluated for the development of the guideline.
The guidelines are intended to reduce practice variation and promote high-value care. The current evidence supports the early prophylactic use of thiopurines and/or anti-TNF therapy in patients who are at higher risk for clinical recurrence. However, some patients at lower risk may opt for close endoscopic monitoring instead. Although all patients should undergo ileocolonoscopy at six to 12 months after surgical resection, surveillance for endoscopic recurrence is most important for patients not on any pharmacological prophylaxis. In general, those with endoscopic recurrence should undergo treatment with anti-TNF and/or thiopurine therapy.
This guideline is available in the January issue of Gastroenterology.
AGA Institute Guidelines for the Diagnosis and Management of Acute Liver Failure: AGA developed this guideline and technical review to provide recommendations about controversial diagnostic and treatment strategies and predictive models for outcome of acute liver failure (ALF), which have arisen since acute liver failure is difficult to study in randomized clinical trials.
Recommendations include a strong recommendation for the use of N-acetyl cysteine (NAC) in patients with ALF related to acetaminophen, but there remains a lack of data to allow recommendations for testing for Wilson’s disease and varicella zoster virus in patients with ALF. Although there are low-quality data, because there are therapies that may be beneficial in patients with ALF, recommendations to test for herpes simplex virus and autoimmune hepatitis are supported, as is hepatitis E virus testing in pregnant women with ALF.
This guideline is available in the February issue of Gastroenterology.
Announcing New Crohn’s & Colitis Congress
AGA and the Crohn’s & Colitis Foundation are partnering to co-sponsor a new annual conference for health-care professionals and researchers. By joining the nation’s leading IBD patient organization with the premier GI professional organization, this will be the must-attend IBD conference, bringing state-of-the-art comprehensive care together with the latest research to advance prevention, treatment and cures for IBD patients.
Save the date – Jan. 18-20, 2018, in Las Vegas. Get ready to expand your knowledge, network with other leaders, and be inspired! Stay tuned for our website launch and more details coming this spring.
Introducing a New, Private Community Just for AGA’s Trainee and Early Career Members
Networking is an important part of your career, between connecting with mentors, gaining valuable referrals and tackling that next rung on the career ladder. AGA created the Early Career Group in the AGA Community to help you connect and network through the forum and directory, but also to provide education tools you’re not going to find anywhere else.
In case you haven’t yet taken a tour, the group creates an open dialogue for trainees and early career members up to seven years out of training. Each month will host a new theme and corresponding presentation, webinars, journal articles or tip sheets, as well as other member-only online events, such as forums with leading experts in the field.
Also, the group’s event calendar will help you stay on top of important deadlines, conferences and possibly even local meet-ups.
Visit http://Community.Gastro.org/EarlyCareerGroup/ today to take advantage of this collaboration space created just for you.
18 GIs to Watch: The Newest Class of AGA Future Leaders
AGA has announced the second class of its Future Leaders Program, which was created in 2015 to identify early career gastroenterologists who have the potential to make a significant impact on the specialty. The 18 gastroenterologists selected to participate in the 2017-2018 program stood out for their current achievements, commitment to advancing the field, and potential for future success.
“AGA relies heavily on the engagement and expertise of volunteer leaders to develop programs that continue to advance our specialty and support our members through changes to the health-care delivery landscape,” said Suzanne Rose, MD, MSEd, AGAF, co-program chair for the AGA Future Leaders Program. “The newest class of AGA Future Leaders shows exceptional promise and dedication to the field, and we look forward to working with these rising stars to cultivate the future leaders of AGA and the field of gastroenterology.”
The AGA Future Leaders Program provides a pathway within AGA for selected participants who seek opportunities to support the gastroenterology profession, advance their careers, connect with potential mentors and develop the leadership skills necessary to serve the organization. During this year-long program, participants will receive leadership training and work closely with AGA mentors on projects linked to AGA’s Strategic Plan.
AGA is pleased to announce the second class of the Future Leaders program:
- Arthur Beyder, MD, PhD, Assistant Professor, Mayo Clinic-Rochester
- Brigid S. Boland, MD, Assistant Adjunct Professor of Medicine, University of California, San Diego
- Lea Ann Chen, MD, Assistant Professor of Medicine, New York University School of Medicine, NY
- Bruno P. Chumpitazi, MD, MPH, Director, Neurogastroenterology and Motility Program, Texas Children’s Hospital/Baylor College of Medicine, Houston, TX
- Matthew A. Ciorba, MD, Assistant Professor of Medicine, Washington University in St. Louis, MO
- Katherine S. Garman, MD, Assistant Professor of Medicine, Duke University Medical Center, Durham, NC
- Christina Y. Ha, MD, Assistant Professor of Medicine, University of Los Angeles, David Geffen School of Medicine, CA
- Bryson W. Katona, MD, MS, PhD, Instructor, University of Pennsylvania, Philadelphia
- Peter S. Liang, MD, MPH, Instructor, NYU/Manhattan VA, New York, NY
- Folasade P. May, MD, PhD, MPhil, Assistant Professor of Medicine, David Geffen School of Medicine at the University of California, Los Angeles; Department of Veterans Affairs, Los Angeles, CA
- Marty M. Meyer, MD, Gastroenterologist, The Ohio State University, Columbus, OH
- Susan N. Ramdhaney, MD, AGAF, Gastroenterologist, President Comprehensive Digestive Care, Manhasset, NY
- Jonathan A. Rosenberg, MD, Gastroenterologist, Illinois Gastroenterology Group, Highland Park
- N. Jewel Samadder, MD, Assistant Professor of Medicine, Huntsman Cancer Institute, Salt Lake City, UT
- Siddharth Singh, MD, Assistant Professor of Medicine, University of California, San Diego
- Maria I. Vazquez-Roque, MD, MSc, Gastroenterologist, Mayo Clinic, Jacksonville, FL
- Sachin B. Wani, MD, Associate Professor of Medicine, University of Colorado, Aurora
- Jennifer Weiss, MD, MS, Assistant Professor, University of Wisconsin School of Medicine and Public Health, Madison
Learn more about the AGA Future Leaders program on the AGA website: www.gastro.org.
New AGA Guidelines
AGA recently released new clinical guidelines that provide evidence-based recommendations to help guide your clinical practice decisions based on rigorous systematic reviews of the medical literature.
AGA Institute Guideline on the Management of Crohn’s Disease After Surgical Resection: AGA developed this guideline, technical review and Clinical Decision Support Tool to outline strategies to reduce disease recurrence in Crohn’s disease patients who have achieved remission following bowel resection. Prevention of endoscopic recurrence, a strong surrogate measure of surgical recurrence, was evaluated for the development of the guideline.
The guidelines are intended to reduce practice variation and promote high-value care. The current evidence supports the early prophylactic use of thiopurines and/or anti-TNF therapy in patients who are at higher risk for clinical recurrence. However, some patients at lower risk may opt for close endoscopic monitoring instead. Although all patients should undergo ileocolonoscopy at six to 12 months after surgical resection, surveillance for endoscopic recurrence is most important for patients not on any pharmacological prophylaxis. In general, those with endoscopic recurrence should undergo treatment with anti-TNF and/or thiopurine therapy.
This guideline is available in the January issue of Gastroenterology.
AGA Institute Guidelines for the Diagnosis and Management of Acute Liver Failure: AGA developed this guideline and technical review to provide recommendations about controversial diagnostic and treatment strategies and predictive models for outcome of acute liver failure (ALF), which have arisen since acute liver failure is difficult to study in randomized clinical trials.
Recommendations include a strong recommendation for the use of N-acetyl cysteine (NAC) in patients with ALF related to acetaminophen, but there remains a lack of data to allow recommendations for testing for Wilson’s disease and varicella zoster virus in patients with ALF. Although there are low-quality data, because there are therapies that may be beneficial in patients with ALF, recommendations to test for herpes simplex virus and autoimmune hepatitis are supported, as is hepatitis E virus testing in pregnant women with ALF.
This guideline is available in the February issue of Gastroenterology.
Announcing New Crohn’s & Colitis Congress
AGA and the Crohn’s & Colitis Foundation are partnering to co-sponsor a new annual conference for health-care professionals and researchers. By joining the nation’s leading IBD patient organization with the premier GI professional organization, this will be the must-attend IBD conference, bringing state-of-the-art comprehensive care together with the latest research to advance prevention, treatment and cures for IBD patients.
Save the date – Jan. 18-20, 2018, in Las Vegas. Get ready to expand your knowledge, network with other leaders, and be inspired! Stay tuned for our website launch and more details coming this spring.
